Overview

Why Invest

Profitable specialty pharmaceutical company with a diversified portfolio 

Cipher’s lean operating structure and collaborative approach to commercialization and development enable rapid and efficient scaling while maximizing our profitability.

  •  
  • Solid dermatology platform
  •  
  • Established presence across the Americas
  •  
  • Strong balance sheet
  •  
  • History of positive operating cash flow
  •  
  • Robust pipeline
  •  
  • Proven leadership team

Download Investor Presentation

Latest News
Oct 8, 2024

Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced today the appointment of Hamed Ghanei as Chief Business Officer ("CBO"). Craig Mull, Interim Chief...

Sep 24, 2024

MISSISSAUGA, ON / ACCESSWIRE / September 24, 2024 / Cipher Pharmaceuticals Inc (TSX:CPH)(OTCQX:CPHRF) ("Cipher") today announced that it will be presenting and participating in 1x1 meetings at the...

Sep 13, 2024

Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announced today that its partner, Moberg Pharma AB ("Moberg"), issued a news release earlier today stating that it...

More News >

Ticker
TSXCPH
Latest Event

Annual Reports

Quarterly Reports